Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001017491-16-000129
Filing Date
2016-04-05
Accepted
2016-04-05 20:45:15
Documents
2
Period of Report
2016-04-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_145990350377579.html 3  
1 FORM 3 wf-form3_145990350377579.xml 3 7425
2 MORTON POWER OF ATTORNEY mortonneilpoa.htm EX-24 8844
  Complete submission text file 0001017491-16-000129.txt   17776
Mailing Address 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO, CA 92130
Business Address 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO, CA 92130 (858) 222-8041
APRICUS BIOSCIENCES, INC. (Issuer) CIK: 0001017491 (see all company filings)

EIN.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O APRICUS BIOSCIENCES, INC. 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO CA 92130
Business Address
Morton Neil (Reporting) CIK: 0001670896 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-22245 | Film No.: 161556379